Zobrazeno 1 - 10
of 117
pro vyhledávání: '"J. G. Jurcic"'
Autor:
D. A. Sallman, M. M. Al Malki, A. S. Asch, E. S. Wang, J. G. Jurcic, T. J. Bradley, I. W. Flinn, D. A. Pollyea, S. N. Kambhampati, T. N. Tanaka, J. F. Zeidner, G. Garcia-Manero, D. Jeyakumar, L. Gu, A. Tan, M. Chao, C. O’Hear, I. Lal, P. Vyas, N. Daver
Publikováno v:
HemaSphere, Vol 6, Pp 67-68 (2022)
Externí odkaz:
https://doaj.org/article/f11a8ee031f8479881eff9499ea7ccf4
Publikováno v:
Current topics in microbiology and immunology. 313
Acute promyelocytic leukemia (APL) is a rare subtype of acute myeloid leukemia (AML) for which a number of targeted therapies have been developed. The "targets" have included both genotypic and phenotypic features of the disease. The application of m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::65ad867f4e9ef6894eb12b738af86153
https://pubmed.ncbi.nlm.nih.gov/17217045
https://pubmed.ncbi.nlm.nih.gov/17217045
Autor:
J. G. Jurcic
Publikováno v:
Haematology and Blood Transfusion Hämatologie und Bluttransfusion ISBN: 9783642639494
In recent years, monoclonal antibodies have become an important cancer therapeutic modality. Genetically engineered humanized antibodies have demonstrated activity against both minimal residual disease and overt leukemia. High-dose radioimmunotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::20815376cc6519ea641a4efe4c31e717
https://doi.org/10.1007/978-3-642-59358-1_30
https://doi.org/10.1007/978-3-642-59358-1_30
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 42(1)
Kinetic analysis of gamma camera patient images can provide time-dependent information about antibody behavior. Current region-of-interest-based techniques for the kinetic analysis of these images rely on user selection and drawing of regions to be a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::82f32ee16ce76dee9222e496f7f8512d
https://pubmed.ncbi.nlm.nih.gov/11197975
https://pubmed.ncbi.nlm.nih.gov/11197975
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 6(2)
Despite achieving complete remission with retinoic acid (RA), most patients with acute promyelocytic leukemia (APL) have minimal residual disease detectable by reverse transcription-PCR (RT-PCR) amplification. HuM195, a humanized monoclonal antibody
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5d0955bed17ea9caa28c6fb03379beaf
https://pubmed.ncbi.nlm.nih.gov/10690513
https://pubmed.ncbi.nlm.nih.gov/10690513
Autor:
G, Sgouros, A M, Ballangrud, J G, Jurcic, M R, McDevitt, J L, Humm, Y E, Erdi, B M, Mehta, R D, Finn, S M, Larson, D A, Scheinberg
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 40(11)
Data from nine patients with leukemia participating in a phase I activity-escalation study of HuM195, labeled with the alpha-particle emitter 213Bi (half-life = 45.6 min), were used to estimate pharmacokinetics and dosimetry. This is the first trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f3c5ba0dfbdef0ea96c25f4a2672ab2a
https://pubmed.ncbi.nlm.nih.gov/10994745
https://pubmed.ncbi.nlm.nih.gov/10994745
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 5(10)
HuM195 is a recombinant humanized IgG1 monoclonal antibody reactive with CD33, a Mr 67,000 glycoprotein expressed on early myeloid progenitor cells and myeloid leukemia cells. HuM195 has been shown to rapidly target and saturate acute myeloid leukemi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d179efe40167f62a853c941b02233ef9
https://pubmed.ncbi.nlm.nih.gov/10537338
https://pubmed.ncbi.nlm.nih.gov/10537338
Autor:
J G, Jurcic, D A, Scheinberg
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 1(12)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::eabe4699c970d623fbc25c6cab5d6d6b
https://pubmed.ncbi.nlm.nih.gov/9815942
https://pubmed.ncbi.nlm.nih.gov/9815942
Autor:
J G, Jurcic, P C, Caron, T K, Nikula, E B, Papadopoulos, R D, Finn, O A, Gansow, W H, Miller, M W, Geerlings, R P, Warrell, S M, Larson
Publikováno v:
Cancer research. 55
M195, a mouse monoclonal antibody reactive with the early myeloid antigen CD33, has been shown to target leukemia cells in patients and to reduce large leukemic burdens when labeled with 131I. A complementarity-determining region-grafted, humanized v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::eda92ffd21cf3b7ee884d5a3fbaea78d
https://pubmed.ncbi.nlm.nih.gov/7493368
https://pubmed.ncbi.nlm.nih.gov/7493368
Autor:
J G, Jurcic, P C, Caron, W H, Miller, T J, Yao, P, Maslak, R D, Finn, S M, Larson, R P, Warrell, D A, Scheinberg
Publikováno v:
Leukemia. 9(2)
Acute promyelocytic leukemia (APL) provides a model to examine the sequential use of selective oncogene product-targeted and lineage-targeted agents. All-trans retinoic acid (RA) has been shown to produce brief remissions by a novel differentiating m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ca186c755ac7b56ab9782728aab348a8
https://pubmed.ncbi.nlm.nih.gov/7869759
https://pubmed.ncbi.nlm.nih.gov/7869759